Data:
{
"symbol": "BHVN",
"price": 17.21,
"marketCap": 2591154500,
"beta": 3.162,
"lastDividend": 0,
"range": "7.48-18.566",
"change": 2.83,
"changePercentage": 19.6801,
"volume": 13668343,
"averageVolume": 2564340,
"companyName": "Biohaven Ltd.",
"currency": "USD",
"cik": "0001935979",
"isin": "VGG1110E1079",
"cusip": "G1110E107",
"exchangeFullName": "New York Stock Exchange",
"exchange": "NYSE",
"industry": "Biotechnology",
"website": "https://www.biohaven.com",
"description": "Biohaven Ltd. operates as a biopharmaceutical firm actively engaged in clinical trials. Its primary objective is to advance innovative treatments for disorders affecting the nervous and immune systems, with the potential to transform current medical interventions.",
"ceo": "Vladimir Coric",
"sector": "Healthcare",
"country": "US",
"fullTimeEmployees": "274",
"phone": "203 404 0410",
"address": "215 Church Street",
"city": "New Haven",
"state": "CT",
"zip": "06510",
"image": "https://images.financialmodelingprep.com/symbol/BHVN.png",
"ipoDate": "2022-09-23",
"defaultImage": false,
"isEtf": false,
"isActivelyTrading": true,
"isAdr": false,
"isFund": false
}
Data:
{
"symbol": "BHVN",
"name": "Biohaven Ltd.",
"price": 15.75,
"changePercentage": -7.07965,
"change": -1.2,
"volume": 1132844,
"dayLow": 15.5,
"dayHigh": 17.05,
"yearHigh": 18.566,
"yearLow": 7.48,
"marketCap": 2371335593,
"priceAvg50": 14.6558,
"priceAvg200": 11.45075,
"exchange": "NYSE",
"open": 16.96,
"previousClose": 16.95,
"timestamp": 1787840359,
"chart_vwap_daily": [
{
"t": "2026-07-17",
"v": 15.1848,
"c": 15.44
},
{
"t": "2026-07-20",
"v": 14.9678,
"c": 14.86
},
{
"t": "2026-07-21",
"v": 15.3391,
"c": 15.51
},
{
"t": "2026-07-22",
"v": 14.8416,
"c": 14.75
},
{
"t": "2026-07-23",
"v": 14.5938,
"c": 14.65
},
{
"t": "2026-07-24",
"v": 14.2663,
"c": 14.32
},
{
"t": "2026-07-27",
"v": 14.5602,
"c": 14.51
},
{
"t": "2026-07-28",
"v": 13.834,
"c": 13.77
},
{
"t": "2026-07-29",
"v": 13.5179,
"c": 13.43
},
{
"t": "2026-07-30",
"v": 13.5597,
"c": 13.82
},
{
"t": "2026-07-31",
"v": 13.5006,
"c": 13.5
},
{
"t": "2026-08-03",
"v": 13.4602,
"c": 13.37
},
{
"t": "2026-08-04",
"v": 13.6446,
"c": 13.75
},
{
"t": "2026-08-05",
"v": 13.6195,
"c": 13.63
},
{
"t": "2026-08-06",
"v": 14.2597,
"c": 14.42
},
{
"t": "2026-08-07",
"v": 14.6899,
"c": 14.66
},
{
"t": "2026-08-10",
"v": 14.6221,
"c": 14.54
},
{
"t": "2026-08-11",
"v": 14.2174,
"c": 14.49
},
{
"t": "2026-08-12",
"v": 14.3972,
"c": 14.39
},
{
"t": "2026-08-13",
"v": 14.6772,
"c": 14.85
},
{
"t": "2026-08-14",
"v": 14.6663,
"c": 14.64
},
{
"t": "2026-08-17",
"v": 14.4495,
"c": 14.46
},
{
"t": "2026-08-18",
"v": 13.7532,
"c": 13.57
},
{
"t": "2026-08-19",
"v": 14.0844,
"c": 14.14
},
{
"t": "2026-08-20",
"v": 13.6652,
"c": 13.5
},
{
"t": "2026-08-21",
"v": 14.0592,
"c": 13.85
},
{
"t": "2026-08-24",
"v": 13.7445,
"c": 13.68
},
{
"t": "2026-08-25",
"v": 14.4051,
"c": 14.38
},
{
"t": "2026-08-26",
"v": 16.3077,
"c": 16.95
},
{
"t": "2026-08-27",
"v": 15.911,
"c": 15.76
}
],
"vwap_summary": {
"days": 30,
"days_above": 13,
"days_below": 17,
"pct_days_above": 43,
"position": "below",
"gap_pct": -0.95,
"streak_days": 1
}
}
Data:
{
"volume": 1132844,
"avgVolume": 2564340,
"short_ratio": [
{
"symbol": "BHVN",
"file_date": "2026-08-26",
"date": "20260826",
"short_volume": 3870056,
"short_exempt_volume": 36441,
"total_volume": 7621156,
"short_volume_ratio": 0.5078,
"signal": "Neutral"
}
],
"volume_profile": {
"poc": 14.41,
"vah": 14.86,
"val": 13.24,
"profile": [
{
"price": 13.28,
"volume": 514232
},
{
"price": 13.36,
"volume": 1005994
},
{
"price": 13.44,
"volume": 2137389
},
{
"price": 13.52,
"volume": 1795563
},
{
"price": 13.6,
"volume": 2233191
},
{
"price": 13.69,
"volume": 1927085
},
{
"price": 13.77,
"volume": 1197634
},
{
"price": 13.85,
"volume": 667987
},
{
"price": 13.93,
"volume": 985255
},
{
"price": 14.01,
"volume": 1391512
},
{
"price": 14.09,
"volume": 1943828
},
{
"price": 14.17,
"volume": 2130203
},
{
"price": 14.25,
"volume": 1554459
},
{
"price": 14.33,
"volume": 2581191
},
{
"price": 14.41,
"volume": 3540357
},
{
"price": 14.49,
"volume": 1092539
},
{
"price": 14.58,
"volume": 1633534
},
{
"price": 14.66,
"volume": 1282907
},
{
"price": 14.74,
"volume": 1020755
},
{
"price": 14.82,
"volume": 811871
},
{
"price": 14.9,
"volume": 323063
},
{
"price": 14.98,
"volume": 465871
},
{
"price": 15.06,
"volume": 105249
},
{
"price": 15.14,
"volume": 670387
},
{
"price": 15.22,
"volume": 332407
},
{
"price": 15.3,
"volume": 76820
},
{
"price": 15.39,
"volume": 0
},
{
"price": 15.47,
"volume": 0
},
{
"price": 15.55,
"volume": 0
},
{
"price": 15.63,
"volume": 435632
},
{
"price": 15.71,
"volume": 171838
},
{
"price": 15.79,
"volume": 157697
},
{
"price": 15.87,
"volume": 291010
},
{
"price": 15.95,
"volume": 311904
},
{
"price": 16.03,
"volume": 499361
},
{
"price": 16.11,
"volume": 343086
},
{
"price": 16.19,
"volume": 270703
},
{
"price": 16.28,
"volume": 737821
},
{
"price": 16.36,
"volume": 0
},
{
"price": 16.44,
"volume": 124625
},
{
"price": 16.52,
"volume": 0
},
{
"price": 16.6,
"volume": 594465
},
{
"price": 16.68,
"volume": 711808
},
{
"price": 16.76,
"volume": 116132
},
{
"price": 16.84,
"volume": 183736
},
{
"price": 16.92,
"volume": 0
},
{
"price": 17.0,
"volume": 812655
},
{
"price": 17.08,
"volume": 0
},
{
"price": 17.17,
"volume": 940197
},
{
"price": 17.25,
"volume": 194030
},
{
"price": 17.33,
"volume": 468054
},
{
"price": 17.41,
"volume": 319854
},
{
"price": 17.49,
"volume": 228999
},
{
"price": 17.57,
"volume": 217732
},
{
"price": 17.65,
"volume": 1185399
},
{
"price": 17.73,
"volume": 460453
},
{
"price": 17.81,
"volume": 766875
},
{
"price": 17.89,
"volume": 0
},
{
"price": 17.98,
"volume": 0
},
{
"price": 18.06,
"volume": 756921
}
],
"sessions": 20
}
}
Data:
{
"symbol": "BHVN",
"marketCap": 2372841202,
"enterpriseValueTTM": 2431843202,
"evToSalesTTM": 0,
"evToOperatingCashFlowTTM": -4.755312824724528,
"evToFreeCashFlowTTM": -4.7509000371188,
"evToEBITDATTM": -4.22975595934859,
"netDebtToEBITDATTM": -0.10262341787013186,
"currentRatioTTM": 4.732979029014651,
"incomeQualityTTM": 0.8714370672805751,
"grahamNumberTTM": null,
"grahamNetNetTTM": -0.601785940231532,
"taxBurdenTTM": 1.0021089264795784,
"interestBurdenTTM": 1,
"workingCapitalTTM": 233901000,
"investedCapitalTTM": 268780000,
"returnOnAssetsTTM": -1.5828952443632853,
"operatingReturnOnAssetsTTM": -1.3556624001815696,
"returnOnTangibleAssetsTTM": -1.672154643552197,
"returnOnEquityTTM": -13.289423327332223,
"returnOnInvestedCapitalTTM": -1.8143719084633365,
"returnOnCapitalEmployedTTM": -1.8418630165443504,
"earningsYieldTTM": -0.24719157971623174,
"freeCashFlowYieldTTM": -0.21572029327902745,
"capexToOperatingCashFlowTTM": -0.0009288319205310963,
"capexToDepreciationTTM": 0.046013755691175044,
"capexToRevenueTTM": 0,
"salesGeneralAndAdministrativeToRevenueTTM": 0,
"researchAndDevelopementToRevenueTTM": 0,
"stockBasedCompensationToRevenueTTM": 0,
"intangiblesToTotalAssetsTTM": 0.05337987101437939,
"averageReceivablesTTM": 0,
"averagePayablesTTM": 11268000,
"averageInventoryTTM": 0,
"daysOfSalesOutstandingTTM": 0,
"daysOfPayablesOutstandingTTM": 2141.2154963680387,
"daysOfInventoryOutstandingTTM": 0,
"operatingCycleTTM": 0,
"cashConversionCycleTTM": -2141.2154963680387,
"freeCashFlowToEquityTTM": -511870000,
"freeCashFlowToFirmTTM": -511870000,
"tangibleAssetValueTTM": -7568000,
"netCurrentAssetValueTTM": -61958000,
"grossProfitMarginTTM": 0,
"ebitMarginTTM": 0,
"ebitdaMarginTTM": 0,
"operatingProfitMarginTTM": 0,
"pretaxProfitMarginTTM": 0,
"continuousOperationsProfitMarginTTM": 0,
"netProfitMarginTTM": 0,
"bottomLineProfitMarginTTM": 0,
"receivablesTurnoverTTM": 0,
"payablesTurnoverTTM": 0.17046392603599142,
"inventoryTurnoverTTM": 0,
"fixedAssetTurnoverTTM": 0,
"assetTurnoverTTM": 0,
"quickRatioTTM": 4.732979029014651,
"solvencyRatioTTM": -1.607098129237944,
"cashRatioTTM": 3.798924319320757,
"priceToEarningsRatioTTM": -3.396551724137931,
"priceToEarningsGrowthRatioTTM": -0.06402323926972002,
"forwardPriceToEarningsGrowthRatioTTM": 0.1860944807074087,
"priceToEarningsDilutedRatioTTM": -3.396551724137931,
"priceToEarningsDilutedGrowthRatioTTM": -0.06402323926972002,
"priceToBookRatioTTM": 194.24260605465554,
"priceToSalesRatioTTM": 0,
"priceToFreeCashFlowRatioTTM": -4.635632488717839,
"priceToOperatingCashFlowRatioTTM": -4.642268952961996,
"debtToAssetsRatioTTM": 0.8011970685576646,
"debtToEquityRatioTTM": 24.30330551464572,
"debtToCapitalRatioTTM": 0.960479471766201,
"longTermDebtToCapitalRatioTTM": 0.955016893508329,
"financialLeverageRatioTTM": 30.333742431680577,
"workingCapitalTurnoverRatioTTM": 0,
"operatingCashFlowRatioTTM": -8.16168725462032,
"operatingCashFlowSalesRatioTTM": 0,
"freeCashFlowOperatingCashFlowRatioTTM": 1.0009288319205312,
"debtServiceCoverageRatioTTM": -123.43016281062553,
"interestCoverageRatioTTM": 0,
"shortTermOperatingCashFlowCoverageRatioTTM": -109.55334190231362,
"operatingCashFlowCoverageRatioTTM": -1.7216657969599543,
"capitalExpenditureCoverageRatioTTM": -1076.621052631579,
"dividendPaidAndCapexCoverageRatioTTM": -1076.621052631579,
"dividendPayoutRatioTTM": 0,
"dividendYieldTTM": 0,
"revenuePerShareTTM": 0,
"netIncomePerShareTTM": -3.895739296327812,
"interestDebtPerShareTTM": 1.9718644775752403,
"cashPerShareTTM": 1.7782263038031523,
"bookValuePerShareTTM": 0.08113564948549695,
"tangibleBookValuePerShareTTM": -0.05024010761792186,
"shareholdersEquityPerShareTTM": 0.08113564948549695,
"operatingCashFlowPerShareTTM": -3.3948916272816,
"capexPerShareTTM": 0.0031532837101629074,
"freeCashFlowPerShareTTM": -3.398044910991763,
"netIncomePerEBTTTM": 1.0021089264795784,
"ebtPerEbitTTM": 1.0320085012944031,
"priceToFairValueTTM": 194.24260605465554,
"debtToMarketCapTTM": 0.1113213980680027,
"effectiveTaxRateTTM": -0.0021089264795784196,
"enterpriseValueMultipleTTM": -4.22975595934859,
"dividendPerShareTTM": 0,
"revenue_history": [],
"dcf": {
"symbol": "BHVN",
"date": "2026-08-26",
"dcf": -0.6001345464896783,
"Stock Price": 16.59
},
"statements": {
"income": [
{
"date": "2025-12-31",
"symbol": "BHVN",
"reportedCurrency": "USD",
"cik": "0001935979",
"filingDate": "2026-03-02",
"acceptedDate": "2026-03-02 16:09:33",
"fiscalYear": "2025",
"period": "FY",
"revenue": 0,
"costOfRevenue": 4139999,
"grossProfit": -4139999,
"researchAndDevelopmentExpenses": 635065000,
"generalAndAdministrativeExpenses": 106173000,
"sellingAndMarketingExpenses": 0,
"sellingGeneralAndAdministrativeExpenses": 106173000,
"otherExpenses": 0,
"operatingExpenses": 741238000,
"costAndExpenses": 745378000,
"netInterestIncome": 14585000,
"interestIncome": 14585000,
"interestExpense": 0,
"depreciationAndAmortization": 9922000,
"ebitda": -727458000,
"ebit": -737380000,
"nonOperatingIncomeExcludingInterest": -7998000,
"operatingIncome": -745378000,
"totalOtherIncomeExpensesNet": 7998000,
"incomeBeforeTax": -737380000,
"incomeTaxExpense": 1442000,
"netIncomeFromContinuingOperations": -738822000,
"netIncomeFromDiscontinuedOperations": 0,
"otherAdjustmentsToNetIncome": 0,
"netIncome": -738822000,
"netIncomeDeductions": 0,
"bottomLineNetIncome": -738822000,
"eps": -6.86,
"epsDiluted": -6.86,
"weightedAverageShsOut": 107624885,
"weightedAverageShsOutDil": 107624885
}
],
"balance_sheet": [
{
"date": "2025-12-31",
"symbol": "BHVN",
"reportedCurrency": "USD",
"cik": "0001935979",
"filingDate": "2026-03-02",
"acceptedDate": "2026-03-02 16:09:33",
"fiscalYear": "2025",
"period": "FY",
"cashAndCashEquivalents": 229957000,
"shortTermInvestments": 89180000,
"cashAndShortTermInvestments": 319137000,
"netReceivables": 0,
"accountsReceivables": 0,
"otherReceivables": 0,
"inventory": 0,
"prepaids": 47022000,
"otherCurrentAssets": 2170000,
"totalCurrentAssets": 368329000,
"propertyPlantEquipmentNet": 15964000,
"goodwill": 1390000,
"intangibleAssets": 18400000,
"goodwillAndIntangibleAssets": 19790000,
"longTermInvestments": 0,
"taxAssets": 0,
"otherNonCurrentAssets": 47364000,
"totalNonCurrentAssets": 83118000,
"otherAssets": 0,
"totalAssets": 451447000,
"totalPayables": 11643000,
"accountPayables": 11643000,
"otherPayables": 0,
"accruedExpenses": 39044000,
"shortTermDebt": 0,
"capitalLeaseObligationsCurrent": 5756000,
"taxPayables": 0,
"deferredRevenue": 0,
"otherCurrentLiabilities": 59491000,
"totalCurrentLiabilities": 115934000,
"longTermDebt": 238900000,
"capitalLeaseObligationsNonCurrent": 39958000,
"deferredRevenueNonCurrent": 0,
"deferredTaxLiabilitiesNonCurrent": 0,
"otherNonCurrentLiabilities": 4583000,
"totalNonCurrentLiabilities": 283441000,
"otherLiabilities": 0,
"capitalLeaseObligations": 45714000,
"totalLiabilities": 399375000,
"treasuryStock": 0,
"preferredStock": 0,
"commonStock": 1934276000,
"retainedEarnings": -2084536000,
"additionalPaidInCapital": 193984000,
"accumulatedOtherComprehensiveIncomeLoss": 8348000,
"otherTotalStockholdersEquity": 0,
"totalStockholdersEquity": 52072000,
"totalEquity": 52072000,
"minorityInterest": 0,
"totalLiabilitiesAndTotalEquity": 451447000,
"totalInvestments": 89180000,
"totalDebt": 284614000,
"netDebt": 54657000
}
],
"cash_flow": [
{
"date": "2025-12-31",
"symbol": "BHVN",
"reportedCurrency": "USD",
"cik": "0001935979",
"filingDate": "2026-03-02",
"acceptedDate": "2026-03-02 16:09:33",
"fiscalYear": "2025",
"period": "FY",
"netIncome": -738822000,
"depreciationAndAmortization": 9922000,
"deferredIncomeTax": 0,
"stockBasedCompensation": 112361000,
"changeInWorkingCapital": 1357000,
"accountsReceivables": 0,
"inventory": 0,
"accountsPayables": -6386000,
"otherWorkingCapital": 7743000,
"otherNonCashItems": 5744000,
"netCashProvidedByOperatingActivities": -609438000,
"investmentsInPropertyPlantAndEquipment": -715000,
"acquisitionsNet": 0,
"purchasesOfInvestments": -266875000,
"salesMaturitiesOfInvestments": 570000000,
"otherInvestingActivities": -1849000,
"netCashProvidedByInvestingActivities": 300561000,
"netDebtIssuance": 250000000,
"longTermNetDebtIssuance": 250000000,
"shortTermNetDebtIssuance": 0,
"netStockIssuance": 189311000,
"netCommonStockIssuance": 189311000,
"commonStockIssuance": 189311000,
"commonStockRepurchased": 0,
"netPreferredStockIssuance": 0,
"netDividendsPaid": 0,
"commonDividendsPaid": 0,
"preferredDividendsPaid": 0,
"otherFinancingActivities": -194000,
"netCashProvidedByFinancingActivities": 439117000,
"effectOfForexChangesOnCash": -3000,
"netChangeInCash": 130237000,
"cashAtEndOfPeriod": 232779000,
"cashAtBeginningOfPeriod": 102542000,
"operatingCashFlow": -609438000,
"capitalExpenditure": -715000,
"freeCashFlow": -610153000,
"incomeTaxesPaid": 0,
"interestPaid": 0
}
]
}
}
Data:
{
"price": 15.76,
"rsi": 57.4409800822568,
"sma20": 14.34225000000003,
"sma50": 14.735499999999991,
"sma200": 11.489824999999987,
"adx": 18.735060910511756,
"atr": 1.16,
"atr_pct": 7.36,
"atr_expansion_pct": 72.7,
"di_plus": 29.8,
"di_minus": 12.5,
"high_52w": 18.11,
"low_52w": 7.79,
"structure": {
"ema8": 14.981914458667086,
"ema21": 14.564422391965179,
"ema50": 14.031365595363098,
"ema200": 13.433169963209295,
"ema10": 14.849999704002759,
"ema20": 14.57880490981159,
"ema10_slope_pct": 5.21,
"ema20_slope_pct": 2.54,
"trend_dir": "chop",
"checks": {
"price_above_all": true,
"ema_stacked": true,
"ema21_rising": true,
"ema50_rising": true,
"adx_over_30": false,
"higher_highs_lows": false,
"lower_highs_lows": false,
"near_21ema": false
},
"dist_21ema_pct": 8.2,
"_no_bars": false,
"macd": {
"macd": 0.264,
"signal": 0.058,
"histogram": 0.206
},
"bollinger": {
"mid": 14.34,
"upper": 16.11,
"lower": 12.57,
"width_pct": 24.65
},
"crossover": {
"fresh_cross": false,
"pre_compressed": false,
"held_above_21": true,
"candles_since": 1,
"intraday_support": false
},
"momentum": {
"roc10": 6.1,
"ret_3d": 15.2,
"ret_5d": 16.74,
"roc10_accel": 12.51,
"checks": {
"roc_over_5": true,
"rsi_in_band": true,
"macd_expanding": true,
"top_quartile_3d": false,
"no_big_down": true,
"near_high": false
},
"volume": {
"rvol": 0.45,
"checks": {
"rvol_over_2": false,
"up_vol_beats_down": true,
"obv_new_high": false,
"surge_day": true,
"pullback_declining_vol": false,
"last_up_beats_down": true
}
}
},
"relative_strength": {
"sector": "Healthcare",
"sector_etf": "XLV",
"sector_etf_ret10d": 3.03,
"checks": {
"beats_spy_all": true,
"beats_sector_10d": true,
"rs_line_at_high": true,
"sector_top3": false
}
},
"commodity": {},
"universe": {
"checks": {
"price_over_20": false,
"avg_vol_over_2m": true,
"mcap_over_1b": true,
"no_earnings_7d": true,
"not_lev_etf_spac": true,
"bidask_spread": null,
"dollar_vol_over_10m": true
},
"avg_dollar_vol": 44132291.4,
"avg_vol": 2564340
},
"options": {
"checks": {
"call_vol_2x": false,
"ivr_under_40": true,
"iv_contracting": true,
"oi_calls_above_price": true
},
"vals": {
"call_vol_mult": 0.5,
"iv_rank": 3.0
}
}
}
}
Data:
{
"prior_day": {
"high": 17.05,
"low": 15.5,
"close": 15.76,
"date": "2026-08-27"
},
"woodie_pivots": {
"PP": 16.02,
"R1": 16.53,
"S1": 14.98,
"R2": 17.57,
"S2": 14.47
},
"swing": {
"high_20d": 18.24,
"low_20d": 13,
"high_60d": 18.24,
"low_60d": 9.9
},
"orb": {
"high": 17.05,
"low": 15.71,
"date": "2026-08-27"
},
"vwap": 15.88,
"volume_profile": {
"poc": 14.41,
"vah": 14.86,
"val": 13.24,
"sessions": 20
},
"premarket": {
"date": "2026-08-27",
"high": 17.3,
"low": 16.6,
"last": 16.77,
"volume": 24733,
"gap_pct": -1.08,
"path": "04:15 16.60 -> 07:05 17.00 -> 07:50 16.98 -> 08:35 17.17 -> 09:25 16.77",
"bars": 25,
"last_bar_et": "09:25"
},
"recent_daily": [
{
"d": "2026-07-24",
"o": 14.68,
"h": 14.98,
"l": 13.88,
"c": 14.32,
"v": 1718104.157247
},
{
"d": "2026-07-27",
"o": 14.62,
"h": 14.89,
"l": 14.25,
"c": 14.51,
"v": 1875511.376383
},
{
"d": "2026-07-28",
"o": 14.27,
"h": 14.57,
"l": 13.635,
"c": 13.77,
"v": 3625682.711123
},
{
"d": "2026-07-29",
"o": 13.78,
"h": 14.1,
"l": 13.27,
"c": 13.43,
"v": 1481076.777661
},
{
"d": "2026-07-30",
"o": 13.5,
"h": 13.865,
"l": 13.13,
"c": 13.82,
"v": 1242583.344759
},
{
"d": "2026-07-31",
"o": 13.87,
"h": 13.94,
"l": 13.2527,
"c": 13.5,
"v": 1429790.503655
},
{
"d": "2026-08-03",
"o": 13.51,
"h": 13.7,
"l": 13.13,
"c": 13.37,
"v": 1590030.092865
},
{
"d": "2026-08-04",
"o": 13.66,
"h": 13.785,
"l": 13.32,
"c": 13.75,
"v": 2414540.713322
},
{
"d": "2026-08-05",
"o": 13.82,
"h": 14,
"l": 13.425,
"c": 13.63,
"v": 1433183.143678
},
{
"d": "2026-08-06",
"o": 13.61,
"h": 14.505,
"l": 13.61,
"c": 14.42,
"v": 1881363.662019
},
{
"d": "2026-08-07",
"o": 14.77,
"h": 14.93,
"l": 14.44,
"c": 14.66,
"v": 1121821.19392
},
{
"d": "2026-08-10",
"o": 14.59,
"h": 14.92,
"l": 14.5,
"c": 14.54,
"v": 1377761.521437
},
{
"d": "2026-08-11",
"o": 14,
"h": 14.57,
"l": 13.73,
"c": 14.49,
"v": 2362955.927773
},
{
"d": "2026-08-12",
"o": 14.63,
"h": 14.75,
"l": 14.18,
"c": 14.39,
"v": 2139032.920666
},
{
"d": "2026-08-13",
"o": 14.47,
"h": 15.04,
"l": 14.3,
"c": 14.85,
"v": 1651869.625133
},
{
"d": "2026-08-14",
"o": 14.79,
"h": 14.96,
"l": 14.31,
"c": 14.64,
"v": 1244145.668229
},
{
"d": "2026-08-17",
"o": 14.5,
"h": 14.79,
"l": 14.22,
"c": 14.46,
"v": 1849178.121886
},
{
"d": "2026-08-18",
"o": 14.3,
"h": 14.3,
"l": 13.545,
"c": 13.57,
"v": 1965319.640411
},
{
"d": "2026-08-19",
"o": 13.94,
"h": 14.44,
"l": 13.76,
"c": 14.14,
"v": 1963568.197371
},
{
"d": "2026-08-20",
"o": 13.96,
"h": 14.52,
"l": 13.26,
"c": 13.5,
"v": 4017443.620456
},
{
"d": "2026-08-21",
"o": 13.6,
"h": 14.33,
"l": 13.53,
"c": 13.85,
"v": 2085884.758165
},
{
"d": "2026-08-24",
"o": 13.95,
"h": 14,
"l": 13.56,
"c": 13.68,
"v": 1355524.029605
},
{
"d": "2026-08-25",
"o": 13.96,
"h": 14.86,
"l": 13.92,
"c": 14.38,
"v": 3441599.838785
},
{
"d": "2026-08-26",
"o": 14.24,
"h": 18.24,
"l": 13,
"c": 16.95,
"v": 15767953.27064
},
{
"d": "2026-08-27",
"o": 16.95,
"h": 17.05,
"l": 15.5,
"c": 15.76,
"v": 1132218.474365
}
]
}
Data:
{
"estimates": [
{
"symbol": "BHVN",
"date": "2030-12-31",
"revenueLow": 702841892,
"revenueHigh": 953384355,
"revenueAvg": 828075539,
"ebitdaLow": 0,
"ebitdaHigh": 0,
"ebitdaAvg": 0,
"ebitLow": 0,
"ebitHigh": 0,
"ebitAvg": 0,
"netIncomeLow": 65363822,
"netIncomeHigh": 97365005,
"netIncomeAvg": 81360108,
"sgaExpenseLow": 0,
"sgaExpenseHigh": 0,
"sgaExpenseAvg": 0,
"epsAvg": 0.75596,
"epsHigh": 0.90467,
"epsLow": 0.60733,
"numAnalystsRevenue": 7,
"numAnalystsEps": 11
},
{
"symbol": "BHVN",
"date": "2029-12-31",
"revenueLow": 287668862,
"revenueHigh": 390214351,
"revenueAvg": 338926224,
"ebitdaLow": 0,
"ebitdaHigh": 0,
"ebitdaAvg": 0,
"ebitLow": 0,
"ebitHigh": 0,
"ebitAvg": 0,
"netIncomeLow": -158478720,
"netIncomeHigh": -106391504,
"netIncomeAvg": -132427040,
"sgaExpenseLow": 0,
"sgaExpenseHigh": 0,
"sgaExpenseAvg": 0,
"epsAvg": -1.23045,
"epsHigh": -0.98854,
"epsLow": -1.47251,
"numAnalystsRevenue": 10,
"numAnalystsEps": 7
},
{
"symbol": "BHVN",
"date": "2028-12-31",
"revenueLow": 105825598,
"revenueHigh": 108893493,
"revenueAvg": 107359546,
"ebitdaLow": 0,
"ebitdaHigh": 0,
"ebitdaAvg": 0,
"ebitLow": 0,
"ebitHigh": 0,
"ebitAvg": 0,
"netIncomeLow": -349497826,
"netIncomeHigh": -134912099,
"netIncomeAvg": -330890160,
"sgaExpenseLow": 0,
"sgaExpenseHigh": 0,
"sgaExpenseAvg": 0,
"epsAvg": -2.10249,
"epsHigh": -1.25354,
"epsLow": -3.24737,
"numAnalystsRevenue": 15,
"numAnalystsEps": 14
},
{
"symbol": "BHVN",
"date": "2027-12-31",
"revenueLow": 15761291,
"revenueHigh": 26190591,
"revenueAvg": 20974377,
"ebitdaLow": 0,
"ebitdaHigh": 0,
"ebitdaAvg": 0,
"ebitLow": 0,
"ebitHigh": 0,
"ebitAvg": 0,
"netIncomeLow": -343984203,
"netIncomeHigh": -223124684,
"netIncomeAvg": -283554443.5,
"sgaExpenseLow": 0,
"sgaExpenseHigh": 0,
"sgaExpenseAvg": 0,
"epsAvg": -2.62026,
"epsHigh": -2.07317,
"epsLow": -3.19614,
"numAnalystsRevenue": 10,
"numAnalystsEps": 10
}
],
"price_target": {
"symbol": "BHVN",
"targetHigh": 30,
"targetLow": 10,
"targetConsensus": 17,
"targetMedian": 15
},
"ratings": {
"symbol": "BHVN",
"rating": "D+",
"overallScore": 1,
"discountedCashFlowScore": 1,
"returnOnEquityScore": 1,
"returnOnAssetsScore": 1,
"debtToEquityScore": 1,
"priceToEarningsScore": 1,
"priceToBookScore": 1
},
"grades": [
{
"symbol": "BHVN",
"date": "2026-08-12",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "BHVN",
"date": "2026-08-11",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "BHVN",
"date": "2026-06-29",
"gradingCompany": "B of A Securities",
"previousGrade": "Neutral",
"newGrade": "Underperform",
"action": "downgrade"
},
{
"symbol": "BHVN",
"date": "2026-05-26",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "BHVN",
"date": "2026-05-13",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "BHVN",
"date": "2026-05-05",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "BHVN",
"date": "2026-04-02",
"gradingCompany": "Citigroup",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BHVN",
"date": "2026-03-11",
"gradingCompany": "TD Cowen",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BHVN",
"date": "2026-03-04",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "BHVN",
"date": "2026-03-03",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "BHVN",
"date": "2026-01-21",
"gradingCompany": "RBC Capital",
"previousGrade": "Sector Perform",
"newGrade": "Outperform",
"action": "upgrade"
},
{
"symbol": "BHVN",
"date": "2026-01-06",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "BHVN",
"date": "2025-12-26",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "BHVN",
"date": "2025-12-03",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Neutral",
"action": "downgrade"
},
{
"symbol": "BHVN",
"date": "2025-11-26",
"gradingCompany": "UBS",
"previousGrade": "Buy",
"newGrade": "Neutral",
"action": "downgrade"
},
{
"symbol": "BHVN",
"date": "2025-11-20",
"gradingCompany": "JP Morgan",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "BHVN",
"date": "2025-11-18",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "BHVN",
"date": "2025-11-18",
"gradingCompany": "BTIG",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BHVN",
"date": "2025-11-13",
"gradingCompany": "Citigroup",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BHVN",
"date": "2025-11-06",
"gradingCompany": "BTIG",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BHVN",
"date": "2025-11-06",
"gradingCompany": "Bernstein",
"previousGrade": "Outperform",
"newGrade": "Market Perform",
"action": "downgrade"
},
{
"symbol": "BHVN",
"date": "2025-11-06",
"gradingCompany": "RBC Capital",
"previousGrade": "Sector Perform",
"newGrade": "Sector Perform",
"action": "maintain"
},
{
"symbol": "BHVN",
"date": "2025-11-05",
"gradingCompany": "TD Cowen",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BHVN",
"date": "2025-11-05",
"gradingCompany": "William Blair",
"previousGrade": "Outperform",
"newGrade": "Market Perform",
"action": "downgrade"
},
{
"symbol": "BHVN",
"date": "2025-09-16",
"gradingCompany": "UBS",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
}
]
}
Data:
[
{
"title": "Why Is Biohaven Stock Soaring Wednesday?",
"url": "https://www.benzinga.com/markets/biotech/26/08/61442861/why-is-biohaven-stock-soaring-wednesday",
"source": "benzinga",
"date": "2026-08-26T17:41:29.634000+00:00",
"summary": "Biohaven gains $795M in global licensing deal and $4M lawsuit win. BHVN jumps 13% as William Blair eyes upcoming trial data.",
"image": ""
},
{
"title": "12 Health Care Stocks Moving In Wednesday's Intraday Session",
"url": "https://www.benzinga.com/trading-ideas/movers/26/08/61441814/12-health-care-stocks-moving-wednesday-s-intraday-session",
"source": "benzinga",
"date": "2026-08-26T17:06:23.097000+00:00",
"summary": "Gainers\n\nBiohaven (NYSE:BHVN) shares increased by 16.5% to $16.75 during Wednesday's regular session. The market value of their outstanding shares is at $2.1 billion. \nSCYNEXIS (NASDAQ:SCYX) stock increased by 15.7%",
"image": ""
},
{
"title": "Biohaven shares are trading higher after the company announced that the U.S. District Court for the District of Delaware ruled in its favor in the case against Avilar Therapeutics. Biohaven announced a collaboration agreement under which SK Biopharmaceuticals will obtain an exclusive worldwide license to the company's Kv7 ion channel platform.",
"url": "https://www.benzinga.com/wiim/26/08/61437272/biohaven-shares-are-trading-higher-after-company-announced-u-s-district-court-district-delaware-rule",
"source": "benzinga",
"date": "2026-08-26T14:50:44.697000+00:00",
"summary": "",
"image": ""
},
{
"title": "Biohaven and SK Biopharmaceuticals Enter into Strategic Global Licensing Agreement for Novel Kv7 Ion Channel Platform and Opakalim, Lead Candidate for Epilepsy",
"url": "https://www.gurufocus.com/news/9053732/biohaven-and-sk-biopharmaceuticals-enter-into-strategic-global-licensing-agreement-for-novel-kv7-ion-channel-platform-and-opakalim-lead-candidate-for-epilepsy",
"source": "GuruFocus",
"date": "2026-08-26 03:00:00",
"summary": "Biohaven and SK Biopharmaceuticals Enter into Strategic Global Licensing Agreement for Novel Kv7 Ion Channel Platform and Opakalim, Lead Candida",
"image": "https://images.financialmodelingprep.com/news/biohaven-and-sk-biopharmaceuticals-enter-into-strategic-global-licensing-20260826.png"
},
{
"title": "Biohaven licenses epilepsy drug to South Korea's SK Biopharmaceuticals\u00a0for up to $795 million",
"url": "https://www.reuters.com/legal/litigation/biohaven-licenses-epilepsy-drug-south-koreas-sk-biopharmaceuticals-for-up-795-2026-08-26/",
"source": "Reuters",
"date": "2026-08-26 02:56:48",
"summary": "Biohaven has \u200bentered into \u200ca licensing agreement \u200bwith \u200bSouth Korean drug \u2060maker \u200bSK Biopharmaceuticals \u200bfor Biohaven's epilepsy drug \u200bplatform, \u200bincluding Opakalim, for \u200cup \u2060to $795 million, the companies \u200bsaid \u200bin \u2060a statement \u200bon \u200bWednesday.",
"image": "https://images.financialmodelingprep.com/news/biohaven-licenses-epilepsy-drug-to-south-koreas-sk-biopharmaceuticalsfor-20260826.jpg"
},
{
"title": "Federal Court Enters Judgment Confirming RA Capital and Avilar Therapeutics Willfully and Maliciously Misappropriated Trade Secret Developed at Yale, Formalizing $4 Million Award to Biohaven and Yale University",
"url": "https://www.prnewswire.com/news-releases/federal-court-enters-judgment-confirming-ra-capital-and-avilar-therapeutics-willfully-and-maliciously-misappropriated-trade-secret-developed-at-yale-formalizing-4-million-award-to-biohaven-and-yale-university-302859834.html",
"source": "PRNewsWire",
"date": "2026-08-25 16:41:00",
"summary": "NEW HAVEN, Conn., Aug. 25, 2026 /PRNewswire/ --\u00a0Biohaven Ltd.",
"image": "https://images.financialmodelingprep.com/news/federal-court-enters-judgment-confirming-ra-capital-and-avilar-20260825.jpg"
},
{
"title": "Biohaven Reports Recent Business Developments and Second Quarter 2026 Financial Results",
"url": "https://www.prnewswire.com/news-releases/biohaven-reports-recent-business-developments-and-second-quarter-2026-financial-results-302847335.html",
"source": "PRNewsWire",
"date": "2026-08-10 16:02:00",
"summary": "First extracellular protein degraders in the clinic demonstrate rapid and robust pharmacodynamic effects and compelling safety in nearly 200 individuals dosed, Phase 3 trial underway Positive clinical biomarker and patient data presented from Biohaven's extracellular degrader pla",
"image": "https://images.financialmodelingprep.com/news/biohaven-reports-recent-business-developments-and-second-quarter-2026-20260810.jpg"
},
{
"title": "Biohaven Appoints Technology Investor John Yetimoglu to Board of Directors",
"url": "https://www.prnewswire.com/news-releases/biohaven-appoints-technology-investor-john-yetimoglu-to-board-of-directors-302844391.html",
"source": "PRNewsWire",
"date": "2026-08-06 07:00:00",
"summary": "Infinitum founder and Groq board director brings frontier AI and technology-investing expertise to\u00a0Biohaven as the company advances AI-enabled approaches to drug development NEW HAVEN, Conn., Aug. 6, 2026 /PRNewswire/ -- Biohaven Ltd.",
"image": "https://images.financialmodelingprep.com/news/biohaven-appoints-technology-investor-john-yetimoglu-to-board-of-20260806.jpg"
},
{
"title": "Federal Jury Finds Avilar Therapeutics and RA Capital Willfully and Maliciously Misappropriated Trade Secret Developed at Yale, Awards Biohaven and Yale University $4 Million",
"url": "https://www.prnewswire.com/news-releases/federal-jury-finds-avilar-therapeutics-and-ra-capital-willfully-and-maliciously-misappropriated-trade-secret-developed-at-yale-awards-biohaven-and-yale-university-4-million-302834812.html",
"source": "PRNewsWire",
"date": "2026-07-27 07:00:00",
"summary": "NEW HAVEN, Conn., July 27, 2026 /PRNewswire/ -- Biohaven Ltd.",
"image": "https://images.financialmodelingprep.com/news/federal-jury-finds-avilar-therapeutics-and-ra-capital-willfully-20260727.jpg"
},
{
"title": "Biohaven to Present New Clinical Data at ESMO Congress on BHV-1530, a Novel FGFR3-Directed ADC With a Proprietary Topoisomerase I (TopoIx) Payload",
"url": "https://www.prnewswire.com/news-releases/biohaven-to-present-new-clinical-data-at-esmo-congress-on-bhv-1530-a-novel-fgfr3-directed-adc-with-a-proprietary-topoisomerase-i-topoix-payload-302829238.html",
"source": "PRNewsWire",
"date": "2026-07-20 07:30:00",
"summary": "Biohaven also announces new clinical supply agreement with Regeneron to evaluate BHV-1530 in combination with cemiplimab (Libtayo\u00ae) Early clinical activity observed: Phase 1 dose-escalation data show early tumor reductions in patients with Fibroblast Growth Factor Receptor (FGFR)",
"image": "https://images.financialmodelingprep.com/news/biohaven-to-present-new-clinical-data-at-esmo-congress-20260720.jpg"
},
{
"title": "Biohaven: Nice Pipeline Momentum, But Its Runway Is A Risk",
"url": "https://seekingalpha.com/article/4921550-biohaven-stock-nice-pipeline-momentum-but-its-runway-is-a-risk",
"source": "Seeking Alpha",
"date": "2026-07-13 08:17:31",
"summary": "Biohaven's pipeline is now more focused after having to narrow down its R&D efforts to other assets. Today, I think opakalim's pivotal epilepsy readout is probably the most important near-term catalyst that could validate their pipeline. They also have interesting, albeit early, ",
"image": "https://images.financialmodelingprep.com/news/biohaven-nice-pipeline-momentum-but-its-runway-is-a-20260713.jpg"
},
{
"title": "Biohaven Announces Scientific Leadership Transitions",
"url": "https://www.prnewswire.com/news-releases/biohaven-announces-scientific-leadership-transitions-302822263.html",
"source": "PRNewsWire",
"date": "2026-07-09 17:00:00",
"summary": "David Pirman, Ph.D. promoted to Executive Vice President and Head of Discovery Bruce Car, Ph.D.",
"image": "https://images.financialmodelingprep.com/news/biohaven-announces-scientific-leadership-transitions-20260709.jpg"
},
{
"title": "Biohaven Completes Enrollment in RISE 3 Pivotal Focal Epilepsy Study with Opakalim, a Selective Kv7.2/7.3 Activator",
"url": "https://www.prnewswire.com/news-releases/biohaven-completes-enrollment-in-rise-3-pivotal-focal-epilepsy-study-with-opakalim-a-selective-kv7-27-3-activator-302813944.html",
"source": "PRNewsWire",
"date": "2026-06-30 07:30:00",
"summary": "Enrollment complete in pivotal Phase 2/3 study evaluating opakalim in focal epilepsy (RISE3); top-line results on track for 2H 2026 Emerging opakalim focal epilepsy and idiopathic generalized epilepsy data presented at recent R&D Day reinforce evidence of target engagement, poten",
"image": "https://images.financialmodelingprep.com/news/biohaven-completes-enrollment-in-rise-3-pivotal-focal-epilepsy-20260630.jpg"
},
{
"title": "Analyst Warns Biohaven's Lead Drug May Struggle To Stand Out",
"url": "https://www.benzinga.com/analyst-stock-ratings/downgrades/26/06/60168944/analyst-warns-biohavens-lead-drug-may-struggle-to-stand-out",
"source": "Benzinga",
"date": "2026-06-29 14:04:13",
"summary": "Biohaven Ltd. (NYSE:BHVN) shares fell Monday after Bank of America Securities (BofA) downgraded the biotechnology company, citing an unfavorable risk-reward profile ahead of a key late-stage epilepsy trial.",
"image": "https://images.financialmodelingprep.com/news/analyst-warns-biohavens-lead-drug-may-struggle-to-stand-20260629.jpg"
},
{
"title": "Biohaven, Goodyear Tire And Other Big Stocks Moving Lower In Monday's Pre-Market Session",
"url": "https://www.benzinga.com/trading-ideas/movers/26/06/60153200/biohaven-goodyear-tire-and-other-big-stocks-moving-lower-in-mondays-pre-market-session",
"source": "Benzinga",
"date": "2026-06-29 08:11:03",
"summary": "U.S. stock futures were higher this morning, with the Nasdaq 100 futures gaining more than 1% on Monday.",
"image": "https://images.financialmodelingprep.com/news/biohaven-goodyear-tire-and-other-big-stocks-moving-lower-20260629.jpg"
},
{
"title": "Biohaven Advances a New Class of Precision Immunology Therapies: First MoDE Extracellular Protein Degrader, BHV-1300, Begins Phase 3 Pivotal Trial in Graves' Disease",
"url": "https://www.prnewswire.com/news-releases/biohaven-advances-a-new-class-of-precision-immunology-therapies-first-mode-extracellular-protein-degrader-bhv-1300-begins-phase-3-pivotal-trial-in-graves-disease-302812720.html",
"source": "PRNewsWire",
"date": "2026-06-29 07:30:00",
"summary": "BHV-1300 is the first MoDE\u2122 extracellular protein degrader to enter a pivotal trial, pioneering a new class of precision immunology medicines that eliminate the disease-driving antibodies at the root of autoimmune disease. BHV-1300 targets the TSHR-IgG1 autoantibody that drives G",
"image": "https://images.financialmodelingprep.com/news/biohaven-advances-a-new-class-of-precision-immunology-therapies-20260629.jpg"
},
{
"title": "Biohaven Stock Down 70% but One Fund's New $6 Million Bet Signals Turnaround Potential",
"url": "https://www.fool.com/coverage/filings/2026/03/23/biohaven-stock-down-70-but-one-fund-s-new-usd6-million-bet-signals-turnaround-potential/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-03-23T17:17:23Z",
"summary": "Sarissa Capital Management established a new $5.79 million position in clinical-stage biotech Biohaven, acquiring 513,184 shares during Q4 2025. Despite the stock falling 70% over the past year due to FDA rejection of troriluzole and disappointing trial results, the fund's invest",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fcdn.content.foolcdn.com%2Fimages%2F1umn9qeh%2Fproduction%2Fa8dc9bdd81bcb1d3921f5c802e4640087b0081c9-1401x1251.png%3Frect%3D76%2C0%2C1251%2C1251%26w%3D384%26h%3D384%26q%3D75%26fit%3Dcrop%26auto%3Dformat&w=1200&op=resize"
},
{
"title": "Biohaven (BHVN) Stock Is Trending Overnight \u2014 Here's What You Should Know",
"url": "https://www.benzinga.com/markets/equities/26/01/49925544/biohaven-bhvn-stock-is-trending-overnight-heres-what-you-should-know?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel",
"source": "Benzinga",
"date": "2026-01-15T02:48:31Z",
"summary": "Biohaven shares surged 6.65% in regular trading and 3.42% in after-hours trading following an investor presentation at the J.P. Morgan Healthcare Conference. The company presented Phase 1 data for BHV-1400 showing significant reductions in IgA nephropathy markers and clinical imp",
"image": "https://cdn.benzinga.com/files/images/story/2026/01/14/Stock-Market-Analysis-With-Candlestick-C.jpeg?width=1200&height=800&fit=crop"
},
{
"title": "Stock Market Today: Dow Jones, S&P 500, Nasdaq Futures Decline After Christmas Day\u2014Nvidia, Sobr Safe, Biohaven In Focus (UPDATED)",
"url": "https://www.benzinga.com/markets/equities/25/12/49591446/stock-market-today-dow-jones-sp-500-futures-slip-after-christmas-day-nvidia-sobr-safe-biohaven-i?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel",
"source": "Benzinga",
"date": "2025-12-26T14:26:49Z",
"summary": "U.S. stock futures declined on Friday following Wednesday's gains, with major indices showing modest losses. Key movers included Nvidia rising on a licensing agreement with Groq, Dynavax surging 38% on Sanofi acquisition news, Sobr Safe dropping 16% after announcing a private pla",
"image": "https://cdn.benzinga.com/files/images/story/2025/12/26/Wall-Street.jpeg?width=1200&height=800&fit=crop"
},
{
"title": "Migraine Clinical Trial Pipeline Expands as 30+ Companies Driving Innovation in Oncology Therapeutics Space | DelveInsight",
"url": "https://www.globenewswire.com/news-release/2025/12/02/3198356/0/en/Migraine-Clinical-Trial-Pipeline-Expands-as-30-Companies-Driving-Innovation-in-Oncology-Therapeutics-Space-DelveInsight.html",
"source": "GlobeNewswire Inc.",
"date": "2025-12-02T18:00:00Z",
"summary": "The migraine therapeutics market is experiencing strong growth, with over 30 companies developing innovative treatments targeting migraine through advanced therapies like CGRP inhibitors and gepants, supported by improved diagnostic recognition and patient awareness.",
"image": "https://ml.globenewswire.com/Resource/Download/dbcddd65-71dd-4559-8875-ae89ac4f96db"
},
{
"title": "Biohaven's Chief Accounting Officer Scooped Up 17,000 Shares. Is the Stock a Buy?",
"url": "https://www.fool.com/coverage/filings/2025/11/19/biohaven-s-chief-accounting-officer-scooped-up-17-000-shares-is-the-stock-a-buy/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2025-11-19T22:15:13Z",
"summary": "Biohaven's Chief Accounting Officer George Clark purchased 17,000 shares despite the company facing challenges, including FDA rejection of its lead drug and significant quarterly losses. The stock is currently not recommended for investment due to precarious business outlook.",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fcdn.content.foolcdn.com%2Fimages%2F1umn9qeh%2Fproduction%2F280eca1b4ecd8cc2401a2f4b2c3a68395e00dc85-1401x1251.png%3Fw%3D1401%26h%3D1251&w=1200&op=resize"
},
{
"title": "Bexorg Raises $42.5M to Transform CNS Drug Development with World\u2019s First Integrated AI and Whole-Human Brain Platform",
"url": "https://www.globenewswire.com/news-release/2025/10/15/3166924/0/en/Bexorg-Raises-42-5M-to-Transform-CNS-Drug-Development-with-World-s-First-Integrated-AI-and-Whole-Human-Brain-Platform.html",
"source": "GlobeNewswire Inc.",
"date": "2025-10-15T11:00:00Z",
"summary": "Bexorg, a biotech startup, secured $42.5M in funding to develop an AI-powered platform for central nervous system drug discovery using whole human brain data, aiming to reduce the historically high clinical trial failure rates in CNS drug development.",
"image": "https://ml.globenewswire.com/Resource/Download/dffe69cc-8553-41f9-b990-5d760e65e59c"
},
{
"title": "10 Health Care Stocks With Whale Alerts In Today's Session",
"url": "https://www.benzinga.com/insights/penny-stocks/25/09/47924360/10-health-care-stocks-with-whale-alerts-in-todays-session",
"source": "Benzinga",
"date": "2025-09-29T17:35:29Z",
"summary": "Multiple health care stocks experienced significant options trading activity, with various bullish and bearish signals across different companies in the sector.",
"image": "https://www.benzinga.com/next-assets/images/schema-image-default.png"
},
{
"title": "BHVN FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Biohaven Ltd. Investors to Secure Counsel Before Important September 12 Deadline in Securities Class Action \u2013 BHVN",
"url": "https://www.globenewswire.com/news-release/2025/09/12/3149273/673/en/BHVN-FINAL-DEADLINE-ROSEN-LEADING-TRIAL-ATTORNEYS-Encourages-Biohaven-Ltd-Investors-to-Secure-Counsel-Before-Important-September-12-Deadline-in-Securities-Class-Action-BHVN.html",
"source": "GlobeNewswire Inc.",
"date": "2025-09-12T14:00:00Z",
"summary": "Rosen Law Firm is notifying Biohaven Ltd. investors about a securities class action lawsuit alleging false statements regarding drug development prospects for troriluzole and BHV-7000.",
"image": "https://ml.globenewswire.com/Resource/Download/745335af-3a3a-4fb5-84c0-fdedc9adf092"
},
{
"title": "BHVN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biohaven Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit",
"url": "https://www.globenewswire.com/news-release/2025/09/11/3148854/9788/en/BHVN-INVESTOR-ALERT-Bronstein-Gewirtz-Grossman-LLC-Announces-that-Biohaven-Ltd-Investors-with-Substantial-Losses-Have-Opportunity-to-Lead-Class-Action-Lawsuit.html",
"source": "GlobeNewswire Inc.",
"date": "2025-09-11T20:00:00Z",
"summary": "A class action lawsuit has been filed against Biohaven Ltd. alleging false and misleading statements about drug development prospects for troriluzole and BHV-7000, potentially impacting the company's business and financial condition.",
"image": "https://ml.globenewswire.com/Resource/Download/1a031130-a9cc-48ff-b281-d1e47c9a91a5"
}
]
Data:
[
{
"symbol": "BHVN",
"date": "2026-11-09",
"epsActual": null,
"epsEstimated": -0.79,
"revenueActual": null,
"revenueEstimated": 735575,
"lastUpdated": "2026-08-27"
},
{
"symbol": "BHVN",
"date": "2026-08-10",
"epsActual": -0.91,
"epsEstimated": -0.76098,
"revenueActual": null,
"revenueEstimated": 490492,
"lastUpdated": "2026-08-27"
},
{
"symbol": "BHVN",
"date": "2026-05-04",
"epsActual": -0.88,
"epsEstimated": -0.86,
"revenueActual": null,
"revenueEstimated": 267436,
"lastUpdated": "2026-08-04"
},
{
"symbol": "BHVN",
"date": "2026-03-02",
"epsActual": -1.21,
"epsEstimated": -1.22,
"revenueActual": null,
"revenueEstimated": 400000,
"lastUpdated": "2026-06-02"
},
{
"symbol": "BHVN",
"date": "2025-11-10",
"epsActual": -1.64,
"epsEstimated": -1.91,
"revenueActual": null,
"revenueEstimated": 375091,
"lastUpdated": "2026-02-10"
}
]
Data:
{
"borrow": [],
"short_interest": [
{
"symbol": "BHVN",
"file_date": "",
"error": "Symbol not found in FINRA biweekly file",
"days_to_cover": null
}
],
"ftd": {
"symbol": "BHVN",
"periods": [
{
"file_period": "202604a",
"settlement_date": "20260414",
"quantity_fails": 549,
"price": 10.12
},
{
"file_period": "202604b",
"settlement_date": "20260420",
"quantity_fails": 7906,
"price": 10.98
},
{
"file_period": "202606a",
"settlement_date": "20260608",
"quantity_fails": 150,
"price": 10.8
},
{
"file_period": "202606b",
"settlement_date": "20260629",
"quantity_fails": 113684,
"price": 15.83
},
{
"file_period": "202607a",
"settlement_date": "20260702",
"quantity_fails": 245,
"price": 15.76
},
{
"file_period": "202607b",
"settlement_date": "20260724",
"quantity_fails": 100,
"price": 14.65
}
],
"trend": "falling",
"trend_description": "FTD quantity declining \u2014 shorts covering or delivery improving"
}
}
Data:
{
"insider": [
{
"symbol": "BHVN",
"filingDate": "2026-08-14",
"transactionDate": "2026-08-06",
"reportingCik": "0002150506",
"companyCik": "0001935979",
"transactionType": "",
"securitiesOwned": 6250000,
"reportingName": "Yetimoglu John",
"typeOfOwner": "director",
"acquisitionOrDisposition": "",
"directOrIndirect": "I",
"formType": "3",
"securitiesTransacted": 0,
"price": 0,
"securityName": "Common Shares",
"url": "https://www.sec.gov/Archives/edgar/data/1935979/000215050626000002/0002150506-26-000002-index.htm"
},
{
"symbol": "BHVN",
"filingDate": "2026-07-17",
"transactionDate": "2026-07-09",
"reportingCik": "0002146037",
"companyCik": "0001935979",
"transactionType": "",
"securitiesOwned": 248212,
"reportingName": "Volles Warren Karl",
"typeOfOwner": "officer: Chief Legal Officer",
"acquisitionOrDisposition": "",
"directOrIndirect": "D",
"formType": "3",
"securitiesTransacted": 0,
"price": 0,
"securityName": "Common Shares",
"url": "https://www.sec.gov/Archives/edgar/data/1935979/000214603726000003/0002146037-26-000003-index.htm"
},
{
"symbol": "BHVN",
"filingDate": "2026-07-17",
"transactionDate": "2026-07-09",
"reportingCik": "0002146037",
"companyCik": "0001935979",
"transactionType": "",
"securitiesOwned": 0,
"reportingName": "Volles Warren Karl",
"typeOfOwner": "officer: Chief Legal Officer",
"acquisitionOrDisposition": "",
"directOrIndirect": "D",
"formType": "3",
"securitiesTransacted": 300000,
"price": 7,
"securityName": "Stock Options (Right to buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1935979/000214603726000003/0002146037-26-000003-index.htm"
},
{
"symbol": "BHVN",
"filingDate": "2026-07-17",
"transactionDate": "2026-07-09",
"reportingCik": "0002146037",
"companyCik": "0001935979",
"transactionType": "",
"securitiesOwned": 0,
"reportingName": "Volles Warren Karl",
"typeOfOwner": "officer: Chief Legal Officer",
"acquisitionOrDisposition": "",
"directOrIndirect": "D",
"formType": "3",
"securitiesTransacted": 78750,
"price": 29.49,
"securityName": "Stock Options (Right to buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1935979/000214603726000003/0002146037-26-000003-index.htm"
},
{
"symbol": "BHVN",
"filingDate": "2026-07-17",
"transactionDate": "2026-07-09",
"reportingCik": "0002146037",
"companyCik": "0001935979",
"transactionType": "",
"securitiesOwned": 0,
"reportingName": "Volles Warren Karl",
"typeOfOwner": "officer: Chief Legal Officer",
"acquisitionOrDisposition": "",
"directOrIndirect": "D",
"formType": "3",
"securitiesTransacted": 95250,
"price": 41.93,
"securityName": "Stock Options (Right to buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1935979/000214603726000003/0002146037-26-000003-index.htm"
},
{
"symbol": "BHVN",
"filingDate": "2026-07-17",
"transactionDate": "2026-07-09",
"reportingCik": "0002146037",
"companyCik": "0001935979",
"transactionType": "",
"securitiesOwned": 0,
"reportingName": "Volles Warren Karl",
"typeOfOwner": "officer: Chief Legal Officer",
"acquisitionOrDisposition": "",
"directOrIndirect": "D",
"formType": "3",
"securitiesTransacted": 83000,
"price": 38.64,
"securityName": "Stock Options (Right to buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1935979/000214603726000003/0002146037-26-000003-index.htm"
},
{
"symbol": "BHVN",
"filingDate": "2026-07-17",
"transactionDate": "2026-07-09",
"reportingCik": "0002146037",
"companyCik": "0001935979",
"transactionType": "",
"securitiesOwned": 0,
"reportingName": "Volles Warren Karl",
"typeOfOwner": "officer: Chief Legal Officer",
"acquisitionOrDisposition": "",
"directOrIndirect": "D",
"formType": "3",
"securitiesTransacted": 175000,
"price": 11.52,
"securityName": "Stock Options (Right to buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1935979/000214603726000003/0002146037-26-000003-index.htm"
},
{
"symbol": "BHVN",
"filingDate": "2026-07-17",
"transactionDate": "2026-07-09",
"reportingCik": "0002146037",
"companyCik": "0001935979",
"transactionType": "",
"securitiesOwned": 0,
"reportingName": "Volles Warren Karl",
"typeOfOwner": "officer: Chief Legal Officer",
"acquisitionOrDisposition": "",
"directOrIndirect": "D",
"formType": "3",
"securitiesTransacted": 14000,
"price": 0,
"securityName": "Restricted Share Unit Award",
"url": "https://www.sec.gov/Archives/edgar/data/1935979/000214603726000003/0002146037-26-000003-index.htm"
}
],
"congress": [
"status",
"endpoint",
"provided",
"message",
"status",
"endpoint",
"provided",
"message"
],
"dark_pool": [
{
"ticker": "BHVN",
"executed_at": "2026-08-27T14:18:31.954000Z",
"size": 1848.0,
"price": 15.745,
"premium": 29096.76,
"volume": 1848.0,
"trade_code": " "
},
{
"ticker": "BHVN",
"executed_at": "2026-08-27T14:18:32.182000Z",
"size": 1700.0,
"price": 15.725,
"premium": 26732.5,
"volume": 1700.0,
"trade_code": " "
},
{
"ticker": "BHVN",
"executed_at": "2026-08-27T14:18:32.009000Z",
"size": 1200.0,
"price": 15.72,
"premium": 18864.0,
"volume": 1200.0,
"trade_code": " "
},
{
"ticker": "BHVN",
"executed_at": "2026-08-27T14:18:32.197000Z",
"size": 651.0,
"price": 15.725,
"premium": 10236.975,
"volume": 651.0,
"trade_code": " "
},
{
"ticker": "BHVN",
"executed_at": "2026-08-27T14:18:39.958000Z",
"size": 600.0,
"price": 15.73,
"premium": 9438.0,
"volume": 600.0,
"trade_code": " "
},
{
"ticker": "BHVN",
"executed_at": "2026-08-27T14:18:32.180000Z",
"size": 592.0,
"price": 15.7,
"premium": 9294.4,
"volume": 592.0,
"trade_code": " "
},
{
"ticker": "BHVN",
"executed_at": "2026-08-27T14:18:32.180000Z",
"size": 592.0,
"price": 15.7,
"premium": 9294.4,
"volume": 592.0,
"trade_code": "F"
},
{
"ticker": "BHVN",
"executed_at": "2026-08-27T14:18:43.714000Z",
"size": 500.0,
"price": 15.74,
"premium": 7870.0,
"volume": 500.0,
"trade_code": " "
}
],
"ats": {
"symbol": "BHVN",
"date": "20260826",
"ats_volume": 0,
"total_volume": 7621156,
"ats_ratio": 0.0,
"ats_pct": 0.0,
"signal": "Low",
"history": [
{
"date": "20260826",
"ats_ratio": 0.0
},
{
"date": "20260825",
"ats_ratio": 0.0
},
{
"date": "20260824",
"ats_ratio": 0.0
},
{
"date": "20260821",
"ats_ratio": 0.0
},
{
"date": "20260820",
"ats_ratio": 0.0
}
]
},
"polygon_dp": {
"ticker": "BHVN",
"days": [
{
"date": "2026-08-27",
"close": 15.76,
"vwap": 15.91,
"volume": 1132218,
"vwap_discount_pct": 0.96
},
{
"date": "2026-08-26",
"close": 16.95,
"vwap": 16.31,
"volume": 15767953,
"vwap_discount_pct": -3.79
},
{
"date": "2026-08-25",
"close": 14.38,
"vwap": 14.41,
"volume": 3441599,
"vwap_discount_pct": 0.17
},
{
"date": "2026-08-24",
"close": 13.68,
"vwap": 13.74,
"volume": 1355524,
"vwap_discount_pct": 0.47
},
{
"date": "2026-08-21",
"close": 13.85,
"vwap": 14.06,
"volume": 2085884,
"vwap_discount_pct": 1.51
}
],
"avg_vwap_discount_pct": -0.14,
"signal": "Neutral"
},
"options_flow": [
{
"executed_at": "2026-08-27T14:13:31.399000Z",
"option_type": "call",
"size": 200,
"price": "2.40",
"delta": "0.643324601142849",
"underlying_price": "15.93",
"sector": "Healthcare",
"implied_volatility": "0.816737989774398",
"volume": 204,
"nbbo_bid": "2.40",
"option_chain_id": "BHVN261016C00015000",
"premium": "48000.00",
"nbbo_ask": "3.10",
"expiry": "2026-10-16",
"open_interest": 5516,
"underlying_symbol": "BHVN",
"strike": "15"
},
{
"executed_at": "2026-08-27T13:30:23.118000Z",
"option_type": "call",
"size": 13,
"price": "8.50",
"delta": "0.806527906641239",
"underlying_price": "16.92",
"sector": "Healthcare",
"implied_volatility": "0.865154733781551",
"volume": 19,
"nbbo_bid": "8.00",
"option_chain_id": "BHVN280121C00012500",
"premium": "11050.00",
"nbbo_ask": "10.70",
"expiry": "2028-01-21",
"open_interest": 138,
"underlying_symbol": "BHVN",
"strike": "12.5"
}
],
"net_premium": {
"ticker": "BHVN",
"net_call_premium": "-69200.00",
"net_put_premium": "-2230.00",
"call_premium": "145787.00",
"put_premium": "37045.00",
"bullish_premium": "45316.00",
"bearish_premium": "112286.00",
"put_call_ratio": "0.59887798036465638149",
"iv_rank": "2.6892",
"implied_move_perc": "0.134000",
"gex_ratio": "0.24023021036253809429",
"gex_net_change": "3080.3322",
"gex_call": "228597.0945",
"gex_put": "-54915.9281",
"gex_net": 173681.1664,
"gex_call_delta": "2773050.2624",
"gex_put_delta": "-298240.4250",
"gex_date": "2026-08-27"
},
"hot_chains": [
{
"underlying_symbol": "BHVN",
"expires": "2026-09-18",
"open_interest": 22,
"option_type": "put",
"delta": -0.342635222449381,
"ask_volume": 151,
"last_price": "0.70",
"implied_volatility": "0.681389163343729",
"gamma": 0.1559292176423927,
"avg_price": "0.7200291545189504373177842566",
"bid_volume": 191,
"nbbo_ask": "0.80",
"strike": "15",
"option_symbol": "BHVN260918P00015000",
"total_premium": "24697.00",
"iv": 0.605856616936997,
"volume": 343,
"nbbo_bid": "0.60"
},
{
"underlying_symbol": "BHVN",
"expires": "2026-10-16",
"open_interest": 5516,
"option_type": "call",
"delta": 0.623412465900941,
"ask_volume": 0,
"last_price": "2.40",
"implied_volatility": "0.816737989774398",
"gamma": 0.0752516745521037,
"avg_price": "2.4078431372549019607843137255",
"bid_volume": 200,
"nbbo_ask": "2.60",
"strike": "15",
"option_symbol": "BHVN261016C00015000",
"total_premium": "49120.00",
"iv": 0.862981079208684,
"volume": 204,
"nbbo_bid": "2.00"
},
{
"underlying_symbol": "BHVN",
"expires": "2026-10-16",
"open_interest": 78,
"option_type": "call",
"delta": 0.13561578371695,
"ask_volume": 83,
"last_price": "0.22",
"implied_volatility": "0.855164219282242",
"gamma": 0.0383500133682008,
"avg_price": "0.2350000000000000000000000000",
"bid_volume": 17,
"nbbo_ask": "0.25",
"strike": "25",
"option_symbol": "BHVN261016C00025000",
"total_premium": "2350.00",
"iv": 0.971327090402196,
"volume": 100,
"nbbo_bid": "0.15"
},
{
"underlying_symbol": "BHVN",
"expires": "2026-10-16",
"open_interest": 1638,
"option_type": "call",
"delta": 0.464755211958393,
"ask_volume": 1,
"last_price": "1.25",
"implied_volatility": "0.75828404518845",
"gamma": 0.0811636464071886,
"avg_price": "1.6553061224489795918367346939",
"bid_volume": 70,
"nbbo_ask": "1.45",
"strike": "17",
"option_symbol": "BHVN261016C00017000",
"total_premium": "16222.00",
"iv": 0.837391723439014,
"volume": 98,
"nbbo_bid": "1.25"
},
{
"underlying_symbol": "BHVN",
"expires": "2026-09-18",
"open_interest": 184,
"option_type": "call",
"delta": 0.255607179822759,
"ask_volume": 2,
"last_price": "0.40",
"implied_volatility": "0.724678926122732",
"gamma": 0.1145177618210648,
"avg_price": "0.4888059701492537313432835822",
"bid_volume": 51,
"nbbo_ask": "0.45",
"strike": "18",
"option_symbol": "BHVN260918C00018000",
"total_premium": "3275.00",
"iv": 0.721730565813281,
"volume": 67,
"nbbo_bid": "0.35"
},
{
"underlying_symbol": "BHVN",
"expires": "2026-09-18",
"open_interest": 20,
"option_type": "put",
"delta": -0.650264989501949,
"ask_volume": 28,
"last_price": "1.92",
"implied_volatility": "0.741729438541163",
"gamma": 0.1449089786956725,
"avg_price": "1.6907936507936507936507936509",
"bid_volume": 30,
"nbbo_ask": "2.05",
"strike": "17",
"option_symbol": "BHVN260918P00017000",
"total_premium": "10652.00",
"iv": 0.656914883285061,
"volume": 63,
"nbbo_bid": "1.65"
},
{
"underlying_symbol": "BHVN",
"expires": "2026-09-18",
"open_interest": 526,
"option_type": "call",
"delta": 0.363644617762122,
"ask_volume": 25,
"last_price": "0.70",
"implied_volatility": "0.750558650489455",
"gamma": 0.1370173505591482,
"avg_price": "1.1051724137931034482758620690",
"bid_volume": 1,
"nbbo_ask": "0.80",
"strike": "17",
"option_symbol": "BHVN260918C00017000",
"total_premium": "3205.00",
"iv": 0.704337041899973,
"volume": 29,
"nbbo_bid": "0.60"
},
{
"underlying_symbol": "BHVN",
"expires": "2026-10-16",
"open_interest": 35,
"option_type": "call",
"delta": 0.325595946446825,
"ask_volume": 27,
"last_price": "1.37",
"implied_volatility": "0.847929036075635",
"gamma": 0.0741128747917223,
"avg_price": "1.37",
"bid_volume": 0,
"nbbo_ask": "1.70",
"strike": "19",
"option_symbol": "BHVN261016C00019000",
"total_premium": "3699.00",
"iv": 0.831209966145999,
"volume": 27,
"nbbo_bid": "1.00"
}
],
"gamma_profile": {
"ticker": "BHVN",
"spot": 15.75,
"date": "2026-08-27",
"flip_point": 14.18,
"net_gex": 173681.17,
"call_walls": [
{
"strike": 15.0,
"gex": 68907.54
},
{
"strike": 20.0,
"gex": 47742.17
},
{
"strike": 22.0,
"gex": 30998.72
}
],
"put_walls": [
{
"strike": 14.0,
"gex": -16889.63
},
{
"strike": 17.0,
"gex": -15403.99
},
{
"strike": 10.0,
"gex": -7789.21
}
],
"by_strike": [
{
"strike": 6.0,
"call_gex": 0.0,
"put_gex": -32.25,
"net_gex": -32.25
},
{
"strike": 7.0,
"call_gex": 1.29,
"put_gex": -5.9,
"net_gex": -4.61
},
{
"strike": 7.5,
"call_gex": 505.96,
"put_gex": -319.97,
"net_gex": 185.99
},
{
"strike": 8.0,
"call_gex": 6.81,
"put_gex": -3.35,
"net_gex": 3.46
},
{
"strike": 9.0,
"call_gex": 71.3,
"put_gex": -937.75,
"net_gex": -866.46
},
{
"strike": 10.0,
"call_gex": 4137.5,
"put_gex": -7789.21,
"net_gex": -3651.7
},
{
"strike": 11.0,
"call_gex": 707.59,
"put_gex": -561.72,
"net_gex": 145.87
},
{
"strike": 12.0,
"call_gex": 3366.73,
"put_gex": -716.78,
"net_gex": 2649.95
},
{
"strike": 12.5,
"call_gex": 3846.53,
"put_gex": -1166.87,
"net_gex": 2679.66
},
{
"strike": 13.0,
"call_gex": 2478.26,
"put_gex": -4117.02,
"net_gex": -1638.75
},
{
"strike": 14.0,
"call_gex": 5695.84,
"put_gex": -16889.63,
"net_gex": -11193.79
},
{
"strike": 15.0,
"call_gex": 68907.54,
"put_gex": -3466.1,
"net_gex": 65441.45
},
{
"strike": 16.0,
"call_gex": 14744.64,
"put_gex": -1160.49,
"net_gex": 13584.15
},
{
"strike": 17.0,
"call_gex": 17842.67,
"put_gex": -15403.99,
"net_gex": 2438.68
},
{
"strike": 17.5,
"call_gex": 1413.86,
"put_gex": -319.88,
"net_gex": 1093.98
},
{
"strike": 18.0,
"call_gex": 4109.51,
"put_gex": -77.91,
"net_gex": 4031.59
},
{
"strike": 19.0,
"call_gex": 1483.24,
"put_gex": 0.0,
"net_gex": 1483.24
},
{
"strike": 20.0,
"call_gex": 47742.17,
"put_gex": -914.63,
"net_gex": 46827.54
},
{
"strike": 21.0,
"call_gex": 914.93,
"put_gex": 0.0,
"net_gex": 914.93
},
{
"strike": 22.0,
"call_gex": 30998.72,
"put_gex": 0.0,
"net_gex": 30998.72
},
{
"strike": 22.5,
"call_gex": 223.43,
"put_gex": -104.74,
"net_gex": 118.69
},
{
"strike": 23.0,
"call_gex": 358.8,
"put_gex": -4.24,
"net_gex": 354.57
},
{
"strike": 24.0,
"call_gex": 13.25,
"put_gex": 0.0,
"net_gex": 13.25
},
{
"strike": 25.0,
"call_gex": 1362.66,
"put_gex": -67.62,
"net_gex": 1295.04
},
{
"strike": 26.0,
"call_gex": 33.9,
"put_gex": 0.0,
"net_gex": 33.9
}
]
},
"oi_changes": {
"net_call_oi_change": 4680,
"net_put_oi_change": 1996,
"top": [
{
"strike": "20",
"oi_change": 2639,
"type": "call"
},
{
"strike": "17",
"oi_change": 2000,
"type": "put"
},
{
"strike": "16",
"oi_change": 1499,
"type": "call"
},
{
"strike": "20",
"oi_change": 648,
"type": "call"
},
{
"strike": "15",
"oi_change": -126,
"type": "call"
}
]
}
}
Data:
{
"vix": 15.85,
"sp500": 7652.86,
"fed_funds": 3.63,
"yield_curve_10y2y": 0.46,
"hy_spread": 2.7,
"treasury": {
"date": "2026-08-25",
"month1": 3.79,
"month2": 3.8,
"month3": 3.86,
"month6": 3.95,
"year1": 4.01,
"year2": 4.17,
"year3": 4.25,
"year5": 4.35,
"year7": 4.48,
"year10": 4.64,
"year20": 5.16,
"year30": 5.17
},
"events": [
{
"title": "Fed Chairman Warsh Speaks",
"currency": "USD",
"date": "2026-08-28",
"time_utc": "14:00",
"impact": "High",
"forecast": null,
"previous": null,
"actual": null,
"minutes_until": 1421
},
{
"title": "Prelim Benchmark Payrolls Revision",
"currency": "USD",
"date": "2026-08-28",
"time_utc": "14:00",
"impact": "High",
"forecast": null,
"previous": "-911K",
"actual": null,
"minutes_until": 1421
}
]
}
Data:
{
"days": 105,
"patterns": [
{
"name": "VWAP Touch",
"count": 105,
"pct": 100
},
{
"name": "9 EMA Touch",
"count": 105,
"pct": 100
},
{
"name": "21 EMA Touch",
"count": 105,
"pct": 100
},
{
"name": "ORB Breakout",
"count": 99,
"pct": 94
},
{
"name": "Woodie Pivot Touch",
"count": 99,
"pct": 94
},
{
"name": "PDH/PDL Touch",
"count": 87,
"pct": 83
},
{
"name": "Open Retracement",
"count": 74,
"pct": 70
},
{
"name": "Gap Fill",
"count": 72,
"pct": 69
},
{
"name": "High Vol Open",
"count": 30,
"pct": 29
},
{
"name": "Darvas Box",
"count": 27,
"pct": 26
},
{
"name": "Power Hour",
"count": 21,
"pct": 20
}
]
}